The SSO Breast Fellows webinars are on-demand programs that provide content on a specific topic and consist of at least two case presentations that are presented by fellows. Topics that are covered include difficult or complicated breast cancer cases.
Breast Cancer During Pregnancy
November 2017
Moderator: Gretchen M. Ahrendt, MD, FACS (University of Colorado-Denver), Susan K. Boolbol, MD (Beth Israel Medical Center and St. Lukes-Roosevelt Hospital Center)
Discussant: Dr. Virginia Borges (University of Colorado-Denver)
Presenting Fellows: Dr. Renee Arlow (University of Pennsylvania) and Dr. Kristin Rojas (Maimonides Medical Center)
Breast Cancer in the Elderly
October 2017
Moderator: Gretchen M. Ahrendt, MD, FACS (University of Colorado-Denver), Susan K. Boolbol, MD (Beth Israel Medical Center and St. Lukes-Roosevelt Hospital Center)
Presenting Fellows: Alison Barron, MD (Mayo Clinic), Abby Geletzke, MD (Women and Infants), Sylvia Reyes, MD (University of Pennsylvania), and Arsalan Salamat, MD (University of Pittsburgh)
Articles to support Scenario 1:
Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomized controlled trial
Articles not supporting Scenario 1:
Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343
Scenario 2: Sentinel node biopsy should routinely be performed in women over the age of 70 with Stage I ER+ breast cancer and a clinically negative axilla.
Articles to support Scenario 2:
Adjuvant Chemotherapy in Older and Younger Women With Lymph Node–Positive Breast Cancer
Breast Cancer Among the Oldest Old: Tumor Characteristics, Treatment Choices, and Survival
Improvement in Breast Cancer Outcomes Over Time: Are Older Women Missing Out?
Articles not supporting Scenario 2:
Association of LN Evaluation with Survival in Women Aged 70 Years or Older With Clinically Node-Negative Hormone Receptor Positive Breast Cancer
Hereditary Breast Cancer Syndromes
June 2017
Moderator: Gretchen M. Ahrendt, MD, FACS (University of Colorado-Denver), Susan K. Boolbol, MD (Beth Israel Medical Center and St. Lukes-Roosevelt Hospital Center)
Discussant: Darcy Thull, MS, CGC (UPMC)
Presenting Fellows: Zeynep Bostanci, MD (City of Hope), Sasa Grae-Espino, MD (Northwestern), & Lerna Ozcan, MD (Cedars-Sinai)
High Risk Lesions in Breast Fellows Webinar
February 2017
Moderator: Gretchen M. Ahrendt, MD, FACS (Magee-Womens Hospital of UPMC), Susan K. Boolbol, MD (Beth Israel Medical Center and St. Lukes-Roosevelt Hospital Center)
Discussant: Amy Degnim, MD (Mayo Clinic)
Presenting Fellows: Kelsey Larson, MD (Cleveland Clinic Foundation), Christine Harris, MD (Anne Arundel Medical Center), & Tolga Ozmen, MD (University of Miami/Jackson Memorial Hospital)
Papilloma on Core Biopsy: Excision vs. Observation
Current management of lesions associated with an increased risk of breast cancer
Radial Scar at Percutaneous Breast Biopsy That Does Not Require Surgery
Radial Scar at Image-guided Needle Biopsy: Is Excision Necessary?
Isolated radial scar diagnosis by core‑needle biopsy: Is surgical excision necessary?
Ductal Carcinoma in Situ Breast Fellows Webinar
April 2016
Moderator: Mary Gemignani, MD (MSKCC)
Discussant: Hiram Cody, MD (MSKCC)
Presenting Fellows: Julie Dunderdale (Northwestern School of Medicine) & Meghan Hansen. MD (University of Texas – Southwestern)
Addressing overtreatment of screen detected DCIS; the LORIS trial
Overview of the Randomized Trials of Radiotherapy in Ductal Carcinoma In Situ of the Breast
Reframing treatment for ductal carcinoma in situ: Could less be more?
The LORIS Trial: Addressing Overtreatment of Ductal Carcinoma In Situ
Trends in Treatment Patterns and Outcomes for Ductal Carcinoma in Situ
Post-Mastectomy Radiation Therapy Breast Webinar
December 2015
Moderator: Gretchen Ahrendt, MD
Discussant: A. Marilyn Leitch, MD
Presenting Fellows: Daniel Farrugia, MD, PhD (UPMC) & Cory Donovan, MD (Cedars-Sinai)